MedPath

Sodium Nitroprusside

Sodium Nitroprusside Injection

Approved
Approval ID

5a689f89-3cbd-f9fa-13cc-26063feb9c83

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 19, 2019

Manufacturers
FDA

Dr.Reddy's Laboratories Inc.,

DUNS: 802315887

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Nitroprusside

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-587
Application NumberANDA210114
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Nitroprusside
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 22, 2016
FDA Product Classification

INGREDIENTS (2)

WaterInactive
Code: 059QF0KO0R
Classification: IACT
Sodium NitroprussideActive
Quantity: 50 mg in 2 mL
Code: EAO03PE1TC
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Nitroprusside - FDA Drug Approval Details